ArticleScience translational medicine2019
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.
Miriam Molina-Arcas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
134 papers cite itlatest 60 shown
this paperpooled itcites it